Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Viral Infections

Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT

Bone Marrow Transplantation volume 25, pages 665–672 (2000)Cite this article

Abstract

In order to evaluate the risk of cytomegalovirus (CMV) associated disease after allogeneic stem cell transplantation (SCT), 158 consecutive patients at risk for infection were analyzed. BMT was performed in 101 patients and peripheral blood stem cell transplantation (PBSCT) in 57 patients. CMV antigenemia was found in 57 cases (56%) after BMT and 27 cases (47%) after PBSCT, respectively. CMV antigenemia resistant to a 14-day course of GCV was found in 26 patients (26%) after BMT but in only four patients (7%) after PBSCT (P < 0.01). Eighteen patients (11%) developed cmv disease, 14 post BMT and four post PBSCT. Lethal CMV-related interstitial pneumonia (CMV-IP) occurred in 13 cases of whom 12 patients were bone marrow recipients (P = 0.04). The subgroup of seronegative patients with a CMV seropositive donor had a significantly lower risk of developing CMV antigenemia, GCV-resistant CMV antigenemia (P < 0.01) and CMV-related disease (P = 0.01). In conclusion, the incidence of persistent CMV antigenemia and CMV-IP was significantly reduced when allogeneic transplantation was performed with peripheral blood stem cells instead of bone marrow. These findings suggest that our previous in vitro data on improved immune reconstitution after allogeneic PBSCT as compared to allogeneic BMT have clinical relevance. Bone Marrow Transplantation (2000) 25, 665–672.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation J Infect Dis 1986 153: 478–488

    Article  CAS  Google Scholar 

  2. Meyers JD, Flournoy N, Thomas ED . Nonbacterial pneumonia after allogeneic marrow transplantation J Infect Dis 1982 4: 1119–1132

    CAS  Google Scholar 

  3. Forman SJ, Zaia JA . Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994 83: 2392–2398

    CAS  PubMed  Google Scholar 

  4. Wingard JR, Mellits ED, Sostrim MB et al. Interstitial pneumonitis after allogeneic bone marrow transplantation: nine year experience in a single institution Medicine 1988 67: 175–186

    Article  CAS  Google Scholar 

  5. Takenaka K, Gondo H, Tanimoto K et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors Bone Marrow Transplant 1997 19: 241–248

    Article  CAS  Google Scholar 

  6. Foot ABM, Pamphilon D, Caul EO et al. Cytomegalovirus infection in recipients of related and unrelated donor bone marrow transplants: no evidence of increased incidence in patients receiving unrelated donor grafts Br J Haematol 1998 102: 671–677

    Article  CAS  Google Scholar 

  7. Gilbert GL, Hayes K, Hudson IL, James J . Prevention of transfusion acquired cytomegalovirus infection in infants by blood filtration to remove leukocytes Lancet 1989 1: 1228–1231

    Article  CAS  Google Scholar 

  8. Bowden RA, Sayers MH, Cays M, Slichter SJ . The role of blood product filtration in the prevention of cytomegalovirus (CMV) infection after bone marrow transplant Transfusion 1989 29: (Suppl.) 57S (Abstr S205)

    Google Scholar 

  9. Goodrich JM, Bowden RA, Fisher L et al. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic BMT Ann Intern Med 1993 118: 173–178

    Article  CAS  Google Scholar 

  10. Winston DJ, Ho WG, Bartoni K et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplantation recipients Ann Intern Med 1993 118: 179–184

    Article  CAS  Google Scholar 

  11. Bacigalupo A, Tedone E, Isaza A et al. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality Bone Marrow Transplant 1995 16: 155–161

    CAS  PubMed  Google Scholar 

  12. Van der Bij W, Schirm J, Torensma R et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood J Clin Microbiol 1988 26: 2531–2535

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Van der Bij W, Torensma R, van Son WJ et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes J Med Virol 1988 21: 179–188

    Article  Google Scholar 

  14. Grefte JM, van der Gun BTF, Schmolke S et al. Cytomegalovirus antigenemia assay: identification of viral antigen as the lower matrix protein pp65 J Infect Dis 1992 166: 683–684

    Article  CAS  Google Scholar 

  15. Brytting M, Xu W, Wahren B, Sundqvist VA . Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infection J Clin Microbiol 1992 30: 1937–1941

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Gerna G, Zipeto D, Parea M et al. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia and DNAemia J Jnfect Dis 1991 164: 488–498

    Article  CAS  Google Scholar 

  17. Boeckh M, Bowden RA, Goodrich JM et al. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic bone marrow transplantation Blood 1992 80: 1358–1363

    CAS  PubMed  Google Scholar 

  18. Ljungman P, De Bock R, Cordonnier C et al. Practice for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplantation recipients: a report from the Working Party for Infectious Disease of the EBMT Bone Marrow Transplant 1993 12: 399–403

    CAS  PubMed  Google Scholar 

  19. Bacigalupo A . Cytomegalovirus (CMV) infections after allogeneic hemopoietic stem cell transplantation (HSCT) Nuove Prospective in Therapia 1998 98: (Suppl.) 1–24

    Google Scholar 

  20. Schmidt GM, Horak DA, Niland JC et al. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants New Engl J Med 1991 324: 1005–1011

    Article  CAS  Google Scholar 

  21. Goodrich JM, Mori M, Gleaves CA et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation New Engl J Med 1991 325: 1601–1607

    Article  CAS  Google Scholar 

  22. Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side-effects of antiviral therapy after bone marrow transplantation Blood 1995 86: 2815–2820

    CAS  PubMed  Google Scholar 

  23. Beelen DW, Ottinger HD, Elmaagacli A et al. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism Blood 1997 90: 4725–4735

    CAS  PubMed  Google Scholar 

  24. Ottinger HD, Beelen DW, Schaefer UW, Grosse-Wilde H . Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 1996 7: 2775–2779

    Google Scholar 

  25. Trenschel R, Bernier M, Delforge A et al. Myeloid and lymphoid recovery following bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic stem cell transplantation Leuk lymphoma 1998 30: 325–352

    Article  CAS  Google Scholar 

  26. Manteiga R, Martino R, Sureda A et al. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem cell transplantation: a single-center experience Bone Marrow Transplant 1998 22: 899–904

    Article  CAS  Google Scholar 

  27. Link H, Arseniev L, Ljungman P et al. Cytomegalovirus infections after allogeneic peripheral blood progenitor cell transplantation (PBSCT) – a survey of the infectious disease working party of EBMT Blood 1997 90: (Suppl. 1) 544a (Abstr. 2424)

    Google Scholar 

  28. Hertenstein B, Hampl W, Bunjes D et al. In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT Bone Marrow Transplant 1995 15: 387–393

    CAS  PubMed  Google Scholar 

  29. Couriel D, Canosa J, Engler H et al. Early reactivation of cytomegalovirus and high risk of interstitial pneumonia following T depleted BMT for adults with hematological malignancies Bone Marrow Transplant 1996 18: 347–353

    CAS  PubMed  Google Scholar 

  30. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage over marrow allografts Blood 1995 85: 1659–1665

    PubMed  Google Scholar 

  31. Bensinger WI, Weaver CH, Appelbaum F et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 1995 85: 1655–1658

    CAS  PubMed  Google Scholar 

  32. Miller W, Flynn P, McCullough J et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-versus-host disease Blood 1986 67: 1162–1167

    CAS  PubMed  Google Scholar 

  33. Cheung KS, Lang DJ . Transmission and activation of cytomegalovirus with blood transfusion: a mouse model J Infect Dis 1977 135: 841–845

    Article  CAS  Google Scholar 

  34. Braun RW, Reiser HC . Replication of human cytomegalovirus in human peripheral blood T cells J Virol 1986 60: 29–36

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Klein HG . Wolf in wolf's clothing: is it time to raise the bounty on passenger leukocyte? Blood 1992 80: 1865–1868

    CAS  PubMed  Google Scholar 

  36. Ishigaki S, Takeda M, Kura T et al. Cytomegalovirus DNA in sera of patients with cytomegalovirus pneumonia Br J Haematol 1991 79: 198–204

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bone Marrow Transplantation and Internal Medicine (Tumor Research), Biometry and Epidemiology, University Hospital of Essen, Essen, Germany

    R Trenschel, H Ottinger, A Elmaagacli, UW Schaefer & V Runde

  2. Institute of Virology, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany

    S Ross & M Roggendorf

  3. Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany

    J Hüsing

Authors
  1. R Trenschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Hüsing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Ottinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Elmaagacli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Roggendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. UW Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V Runde
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trenschel, R., Ross, S., Hüsing, J. et al. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT. Bone Marrow Transplant 25, 665–672 (2000). https://doi.org/10.1038/sj.bmt.1702216

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702216

Keywords

This article is cited by

Search

Advanced search

Quick links